WO2001062264A3 - Halotherapy method by inhalation of sodium chloride - Google Patents
Halotherapy method by inhalation of sodium chloride Download PDFInfo
- Publication number
- WO2001062264A3 WO2001062264A3 PCT/US2001/005591 US0105591W WO0162264A3 WO 2001062264 A3 WO2001062264 A3 WO 2001062264A3 US 0105591 W US0105591 W US 0105591W WO 0162264 A3 WO0162264 A3 WO 0162264A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sodium chloride
- inhalation
- doses
- periods
- administered via
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001241636A AU2001241636A1 (en) | 2000-02-23 | 2001-02-22 | Halotherapy method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2000104735 | 2000-02-23 | ||
RU2000104735/14A RU2000104735A (en) | 2000-02-23 | HALOTHERAPY METHOD |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10257126 A-371-Of-International | 2001-02-23 | ||
US10/267,708 Continuation-In-Part US6919205B2 (en) | 2000-02-23 | 2002-10-09 | Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals |
US10/603,226 Continuation-In-Part US7130692B2 (en) | 2000-02-23 | 2003-06-25 | Portable electrotherapy device for treating osteoarthritis and other diseases, defects and injuries of the knee joint |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001062264A2 WO2001062264A2 (en) | 2001-08-30 |
WO2001062264A3 true WO2001062264A3 (en) | 2002-05-02 |
Family
ID=20231147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/005591 WO2001062264A2 (en) | 2000-02-23 | 2001-02-22 | Halotherapy method by inhalation of sodium chloride |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001241636A1 (en) |
WO (1) | WO2001062264A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743427B1 (en) | 1997-12-02 | 2004-06-01 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
EE00431U1 (en) * | 2003-12-09 | 2004-04-15 | Budarin Vladimir | Method for obtaining a salt aerosol at a predetermined concentration |
RO122397B1 (en) * | 2006-11-14 | 2009-05-29 | Constantin Pascu | Process and device for the controlled production of dry saline aerosols |
US20120018526A1 (en) * | 2009-03-20 | 2012-01-26 | Livia Tiba | Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution |
DE102016218604A1 (en) | 2016-09-27 | 2018-03-29 | Constantin Adams | A particulate mixture, preferably for use in the prophylaxis and / or treatment of an airway disorder |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995028944A1 (en) * | 1994-04-22 | 1995-11-02 | National Heart & Lung Institute | Pharmaceutical inhalation compositions containing a solid active ingredient |
US5487378A (en) * | 1990-12-17 | 1996-01-30 | Minnesota Mining And Manufacturing Company | Inhaler |
WO1996031221A1 (en) * | 1995-04-05 | 1996-10-10 | Genentech, Inc. | Preparation of sodium chloride aerosol formulations |
US5817028A (en) * | 1994-02-25 | 1998-10-06 | Central Sydney Area Health Service | Method and device for the provocation of air passage narrowing and/or the induction of sputum |
WO1998048875A1 (en) * | 1997-04-29 | 1998-11-05 | The Procter & Gamble Company | Method of delivering halotherapy |
-
2001
- 2001-02-22 AU AU2001241636A patent/AU2001241636A1/en not_active Abandoned
- 2001-02-22 WO PCT/US2001/005591 patent/WO2001062264A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5487378A (en) * | 1990-12-17 | 1996-01-30 | Minnesota Mining And Manufacturing Company | Inhaler |
US5817028A (en) * | 1994-02-25 | 1998-10-06 | Central Sydney Area Health Service | Method and device for the provocation of air passage narrowing and/or the induction of sputum |
WO1995028944A1 (en) * | 1994-04-22 | 1995-11-02 | National Heart & Lung Institute | Pharmaceutical inhalation compositions containing a solid active ingredient |
WO1996031221A1 (en) * | 1995-04-05 | 1996-10-10 | Genentech, Inc. | Preparation of sodium chloride aerosol formulations |
WO1998048875A1 (en) * | 1997-04-29 | 1998-11-05 | The Procter & Gamble Company | Method of delivering halotherapy |
Also Published As
Publication number | Publication date |
---|---|
WO2001062264A2 (en) | 2001-08-30 |
AU2001241636A1 (en) | 2001-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5599961B2 (en) | Pharmaceutical composition | |
WO2001064182A3 (en) | Improvements in or relating to the delivery of oral drugs | |
US20210330635A1 (en) | Therapeutic compositions, products of manufacture and methods for ameliorating or preventing coronavirus infection | |
MY129384A (en) | "pharmaceutical formulations for dry powder inhalers in the form of hard-pellets" | |
WO2003032928A3 (en) | Therapeutic composition and use | |
KR20010020346A (en) | Method of delivering halotherapy | |
CA2519175A1 (en) | A method of treating a systemic disease | |
AU2023202420A1 (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
US20230158259A1 (en) | Products of manufacture and methods for treating, ameliorating or preventing microbial infections | |
WO2001062264A3 (en) | Halotherapy method by inhalation of sodium chloride | |
Kunkel et al. | Respimat®(a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients | |
SE0303091D0 (en) | Combined doses of tiotropium andfluticasone | |
O Callaghan et al. | The history of inhaled drug therapy | |
JP2006508994A5 (en) | ||
CZ287114B6 (en) | Therapeutic preparation in the form of aerosol and use of gas mixture | |
PAVIA et al. | Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler | |
US20170224936A1 (en) | Nasal treatment delivery device with carbon dioxide and saline, and methods | |
RU2362559C2 (en) | System of opioids delivery | |
JP2006508993A5 (en) | ||
CN116196298A (en) | Aerosol pharmaceutical composition containing glycopyrronium salt and preparation method and application thereof | |
US20210353536A1 (en) | Applying Fluoride for Treating or Preventing Viral Infection Including SARS-CoV-2 | |
EP3411094A1 (en) | Nasal treatment delivery device with carbon dioxide and saline, and methods, including low flow rates | |
RU2000104735A (en) | HALOTHERAPY METHOD | |
D’Amato et al. | Double-Blind Crossover Study on the Protective Effect of Fenoterol–Administered by Pressurized Aerosol and in Powder Form–in Allergen-Induced Asthma | |
JP2002161030A (en) | Method for inhaling mixed powder having different particle diameter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10257126 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |